United States · 
Who invested in ARS Pharmaceuticals?
ARS Pharmaceuticals's investors include RA Capital Management, Deerfield and SR One.
United States · Funded startup
Who invested in ARS Pharmaceuticals
Funding summaryUpdated 26 Oct 2026
$100Mraised across 1 round since 2025, from 1 source
- Latest round
- Debt, $100MSept 2025
- Investors
- 3
The rounds
- Sept 2025
Founders and team
From the SEC filings it signed: 2 on the team.
- Dana McGowanExecutive Officeri
- Richard LowenthalExecutive Officer, Directori
On the board, as filediBrent SaundersJonathan LeffMike KellyPeter KolchinskyPhil SchneiderPratik ShahRajeev Dadoo
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists ARS Pharmaceuticals as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about ARS Pharmaceuticals
How much has ARS Pharmaceuticals raised?
ARS Pharmaceuticals has raised $100M across 1 round since 2025.
When did ARS Pharmaceuticals last raise?
ARS Pharmaceuticals's most recent round was a Debt of $100M in Sept 2025.
What was ARS Pharmaceuticals's biggest round?
Its most recent round, $100M in Sept 2025, is also its largest on record.
Who backed ARS Pharmaceuticals first?
ARS Pharmaceuticals's first round on record, in Sept 2025, was backed by RA Capital Management, Deerfield and SR One.
What stage is ARS Pharmaceuticals at?
ARS Pharmaceuticals's latest named round is a Debt, in Sept 2025.
Where is ARS Pharmaceuticals based?
ARS Pharmaceuticals is based in the United States.
Companies like ARS Pharmaceuticals
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.